van Der Poel HG - Search Results

1

Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review.

Van den Broeck T, van den Bergh RCN, Arfi N, Gross T, Moris L, Briers E, Cumberbatch M, De Santis M, Tilki D, Fanti S, Fossati N, Gillessen S, Grummet JP, Henry AM, Lardas M, Liew M, Rouvière O, Pecanka J, Mason MD, Schoots IG, van Der Kwast TH, van Der Poel HG, Wiegel T, Willemse PM, Yuan Y, Lam TB, Cornford P, Mottet N. Van den Broeck T, et al. Among authors: van den bergh rcn, van der kwast th, van der poel hg. Eur Urol. 2019 Jun;75(6):967-987. doi: 10.1016/j.eururo.2018.10.011. Epub 2018 Oct 17. Eur Urol. 2019. PMID: 30342843 Free article. Review.

2

Quanticyt: karyometric analysis of bladder washing for patients with superficial bladder cancer.

van der Poel HG, Witjes JA, van Stratum P, Boon ME, Debruyne FM, Schalken JA. van der Poel HG, et al. Among authors: van stratum p. Urology. 1996 Sep;48(3):357-64. doi: 10.1016/S0090-4295(96)00210-5. Urology. 1996. PMID: 8804485 Free article. Clinical Trial.

3

Intratumoral nuclear morphologic heterogeneity in prostate cancer.

van der Poel HG, Oosterhof GO, Schaafsma HE, Debruyne FM, Schalken JA. van der Poel HG, et al. Urology. 1997 Apr;49(4):652-7. doi: 10.1016/s0090-4295(96)00557-2. Urology. 1997. PMID: 9111646 Free article.

4

Bladder wash cytology, quantitative cytology, and the qualitative BTA test in patients with superficial bladder cancer.

Van der Poel HG, Van Balken MR, Schamhart DH, Peelen P, de Reijke T, Debruyne FM, Schalken JA, Witjes JA. Van der Poel HG, et al. Among authors: van balken mr. Urology. 1998 Jan;51(1):44-50. doi: 10.1016/s0090-4295(97)00496-2. Urology. 1998. PMID: 9457287

5

Urinary NMP22 and karyometry in the diagnosis and follow-up of patients with superficial bladder cancer.

Witjes JA, van der Poel HG, van Balken MR, Debruyne FM, Schalken JA. Witjes JA, et al. Among authors: van balken mr, van der poel hg. Eur Urol. 1998;33(4):387-91. doi: 10.1159/000019621. Eur Urol. 1998. PMID: 9612682

6

Presence of carcinoma in situ and high 2C-deviation index are the best predictors of invasive transitional cell carcinoma of the bladder in patients with high-risk Quanticyt.

van Rhijn BW, van der Poel HG, Boon ME, Debruyne FM, Schalken JA, Witjes JA. van Rhijn BW, et al. Among authors: van der poel hg. Urology. 2000 Mar;55(3):363-7. doi: 10.1016/s0090-4295(99)00460-4. Urology. 2000. PMID: 10699611

7

Recurrence of germ cell tumor after orchiectomy.

van der Poel HG, Sedelaar JP, Debruyne FM, Witjes JA. van der Poel HG, et al. Urology. 2000 Sep 1;56(3):467-73. doi: 10.1016/s0090-4295(00)00693-2. Urology. 2000. PMID: 10962317

8

Consecutive quantitative cytology in bladder cancer.

van der Poel HG, van Rhijn BW, Peelen P, Debruyne FM, Boon ME, Schalken JA. van der Poel HG, et al. Among authors: van rhijn bw. Urology. 2000 Oct 1;56(4):584-8. doi: 10.1016/s0090-4295(00)00726-3. Urology. 2000. PMID: 11018610

9

Microvessel density: correlation between contrast ultrasonography and histology of prostate cancer.

Sedelaar JP, van Leenders GJ, Hulsbergen-van de Kaa CA, van der Poel HG, van der Laak JA, Debruyne FM, Wijkstra H, de la Rosette JJ. Sedelaar JP, et al. Among authors: van leenders gj, van der laak ja, van der poel hg. Eur Urol. 2001 Sep;40(3):285-93. doi: 10.1159/000049788. Eur Urol. 2001. PMID: 11684844

10

Smart drugs in prostate cancer.

van der Poel HG. van der Poel HG. Eur Urol. 2004 Jan;45(1):1-17. doi: 10.1016/j.eururo.2003.08.011. Eur Urol. 2004. PMID: 14667509 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

492 results

Search Page